nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.297	0.421	CbGbCtD
Rabeprazole—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.133	0.188	CbGbCtD
Rabeprazole—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.11	0.156	CbGbCtD
Rabeprazole—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.101	0.143	CbGbCtD
Rabeprazole—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0642	0.091	CbGbCtD
Rabeprazole—Vestibular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0112	0.038	CcSEcCtD
Rabeprazole—Tendon disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00862	0.0292	CcSEcCtD
Rabeprazole—Salivary gland enlargement—Cyclosporine—focal segmental glomerulosclerosis	0.0081	0.0275	CcSEcCtD
Rabeprazole—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.00745	0.0253	CcSEcCtD
Rabeprazole—Rheumatoid arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00745	0.0253	CcSEcCtD
Rabeprazole—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.0246	CcSEcCtD
Rabeprazole—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00644	0.0218	CcSEcCtD
Rabeprazole—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.0163	CcSEcCtD
Rabeprazole—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.00472	0.016	CcSEcCtD
Rabeprazole—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.0158	CcSEcCtD
Rabeprazole—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00417	0.0141	CcSEcCtD
Rabeprazole—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00406	0.0138	CcSEcCtD
Rabeprazole—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.0131	CcSEcCtD
Rabeprazole—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00387	0.0131	CcSEcCtD
Rabeprazole—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00383	0.013	CcSEcCtD
Rabeprazole—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.0037	0.0125	CcSEcCtD
Rabeprazole—Psoriasis—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.0121	CcSEcCtD
Rabeprazole—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00354	0.012	CcSEcCtD
Rabeprazole—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.0118	CcSEcCtD
Rabeprazole—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.0118	CcSEcCtD
Rabeprazole—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.0112	CcSEcCtD
Rabeprazole—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0108	CcSEcCtD
Rabeprazole—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0108	CcSEcCtD
Rabeprazole—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00312	0.0106	CcSEcCtD
Rabeprazole—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.0101	CcSEcCtD
Rabeprazole—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00972	CcSEcCtD
Rabeprazole—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00964	CcSEcCtD
Rabeprazole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00893	CcSEcCtD
Rabeprazole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00874	CcSEcCtD
Rabeprazole—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00256	0.00868	CcSEcCtD
Rabeprazole—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.00862	CcSEcCtD
Rabeprazole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.0085	CcSEcCtD
Rabeprazole—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00844	CcSEcCtD
Rabeprazole—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00839	CcSEcCtD
Rabeprazole—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00839	CcSEcCtD
Rabeprazole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00247	0.00839	CcSEcCtD
Rabeprazole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00828	CcSEcCtD
Rabeprazole—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00828	CcSEcCtD
Rabeprazole—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00241	0.00817	CcSEcCtD
Rabeprazole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.00236	0.00801	CcSEcCtD
Rabeprazole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00763	CcSEcCtD
Rabeprazole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00221	0.00749	CcSEcCtD
Rabeprazole—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00736	CcSEcCtD
Rabeprazole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00728	CcSEcCtD
Rabeprazole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00716	CcSEcCtD
Rabeprazole—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00701	CcSEcCtD
Rabeprazole—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00697	CcSEcCtD
Rabeprazole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00697	CcSEcCtD
Rabeprazole—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0069	CcSEcCtD
Rabeprazole—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0069	CcSEcCtD
Rabeprazole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00682	CcSEcCtD
Rabeprazole—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00665	CcSEcCtD
Rabeprazole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00649	CcSEcCtD
Rabeprazole—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00637	CcSEcCtD
Rabeprazole—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00634	CcSEcCtD
Rabeprazole—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00631	CcSEcCtD
Rabeprazole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00625	CcSEcCtD
Rabeprazole—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00619	CcSEcCtD
Rabeprazole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00619	CcSEcCtD
Rabeprazole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00613	CcSEcCtD
Rabeprazole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00597	CcSEcCtD
Rabeprazole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00589	CcSEcCtD
Rabeprazole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0057	CcSEcCtD
Rabeprazole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00554	CcSEcCtD
Rabeprazole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00549	CcSEcCtD
Rabeprazole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00545	CcSEcCtD
Rabeprazole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00507	CcSEcCtD
Rabeprazole—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00506	CcSEcCtD
Rabeprazole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0049	CcSEcCtD
Rabeprazole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00482	CcSEcCtD
Rabeprazole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00479	CcSEcCtD
Rabeprazole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00469	CcSEcCtD
Rabeprazole—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.0046	CcSEcCtD
Rabeprazole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00447	CcSEcCtD
Rabeprazole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00442	CcSEcCtD
Rabeprazole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00435	CcSEcCtD
Rabeprazole—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00433	CcSEcCtD
Rabeprazole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00432	CcSEcCtD
Rabeprazole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00429	CcSEcCtD
Rabeprazole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00421	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00418	CcSEcCtD
Rabeprazole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00418	CcSEcCtD
Rabeprazole—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00416	CcSEcCtD
Rabeprazole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00416	CcSEcCtD
Rabeprazole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00415	CcSEcCtD
Rabeprazole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.00415	CcSEcCtD
Rabeprazole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00407	CcSEcCtD
Rabeprazole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.00402	CcSEcCtD
Rabeprazole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.004	CcSEcCtD
Rabeprazole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00384	CcSEcCtD
Rabeprazole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00383	CcSEcCtD
Rabeprazole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0038	CcSEcCtD
Rabeprazole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00378	CcSEcCtD
Rabeprazole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00375	CcSEcCtD
Rabeprazole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00369	CcSEcCtD
Rabeprazole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00357	CcSEcCtD
Rabeprazole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00348	CcSEcCtD
Rabeprazole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00344	CcSEcCtD
Rabeprazole—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00342	CcSEcCtD
Rabeprazole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000998	0.00338	CcSEcCtD
Rabeprazole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000983	0.00333	CcSEcCtD
Rabeprazole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.00329	CcSEcCtD
Rabeprazole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000965	0.00327	CcSEcCtD
Rabeprazole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000963	0.00327	CcSEcCtD
Rabeprazole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000955	0.00324	CcSEcCtD
Rabeprazole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000945	0.00321	CcSEcCtD
Rabeprazole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000927	0.00314	CcSEcCtD
Rabeprazole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000921	0.00312	CcSEcCtD
Rabeprazole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000912	0.00309	CcSEcCtD
Rabeprazole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000909	0.00308	CcSEcCtD
Rabeprazole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000904	0.00306	CcSEcCtD
Rabeprazole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00305	CcSEcCtD
Rabeprazole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000887	0.00301	CcSEcCtD
Rabeprazole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000883	0.003	CcSEcCtD
Rabeprazole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00088	0.00298	CcSEcCtD
Rabeprazole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.00291	CcSEcCtD
Rabeprazole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000852	0.00289	CcSEcCtD
Rabeprazole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000849	0.00288	CcSEcCtD
Rabeprazole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.00284	CcSEcCtD
Rabeprazole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.00284	CcSEcCtD
Rabeprazole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.00284	CcSEcCtD
Rabeprazole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000834	0.00283	CcSEcCtD
Rabeprazole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000827	0.0028	CcSEcCtD
Rabeprazole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000819	0.00278	CcSEcCtD
Rabeprazole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00274	CcSEcCtD
Rabeprazole—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00272	CcSEcCtD
Rabeprazole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000803	0.00272	CcSEcCtD
Rabeprazole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.00266	CcSEcCtD
Rabeprazole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000776	0.00263	CcSEcCtD
Rabeprazole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.00259	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000731	0.00248	CcSEcCtD
Rabeprazole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000726	0.00246	CcSEcCtD
Rabeprazole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.00244	CcSEcCtD
Rabeprazole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000716	0.00243	CcSEcCtD
Rabeprazole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000713	0.00242	CcSEcCtD
Rabeprazole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.0024	CcSEcCtD
Rabeprazole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000698	0.00237	CcSEcCtD
Rabeprazole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00233	CcSEcCtD
Rabeprazole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.00233	CcSEcCtD
Rabeprazole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000661	0.00224	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000656	0.00223	CcSEcCtD
Rabeprazole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000638	0.00216	CcSEcCtD
Rabeprazole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00215	CcSEcCtD
Rabeprazole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.00215	CcSEcCtD
Rabeprazole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000591	0.002	CcSEcCtD
Rabeprazole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.00195	CcSEcCtD
Rabeprazole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000568	0.00193	CcSEcCtD
Rabeprazole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000549	0.00186	CcSEcCtD
Rabeprazole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000531	0.0018	CcSEcCtD
Rabeprazole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00051	0.00173	CcSEcCtD
Rabeprazole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00172	CcSEcCtD
Rabeprazole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00171	CcSEcCtD
Rabeprazole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000503	0.0017	CcSEcCtD
Rabeprazole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000477	0.00162	CcSEcCtD
